KEY POINTS • Clinical manifestations of CS include heart block, ventricular arrythmias, SCD, and HF. • Among patients with biopsy-proven or a clinical diagnosis of extracardiac sarcoidosis, any signs or…
KEY POINTS • Cardiac amyloidosis is often underdiagnosed, misdiagnosed, or diagnosed late in the natural course of the disease. • Accurate diagnosis and typing of cardiac amyloidosis are both critical…
KEY POINTS • Current conventional methods to assess arrhythmic risk, including their guidance for implantation of a cardioverter defibrillator, have recognized shortcomings. • Radionuclide imaging can enhance other methods to…
KEY POINTS • CAV remains a major limitation for the long-term success of cardiac allografts. • The high prevalence of renal dysfunction has limited the use of invasive coronary angiography….
KEY POINTS • In HF patients, CAD may be causal, contributory, or coincidental. The determination of the role of CAD in the patient’s cardiomyopathy is essential to determine the potential…
KEY POINTS • Myocardial metabolism is inherently and intimately related to cardiac function. • The heart is a metabolic omnivore that uses multiple different substrates for the generation of energy…
KEY POINTS • Radionuclide MPI using SPECT or PET techniques is a widely used approach to identify the presence of CAD-related perfusion abnormalities and assess LV function. • There exists…
KEY POINTS • Noninvasive imaging plays an important role in the evaluation of patients with new-onset HF. • Documentation of angiographic CAD is often a first-line test and is supported…
KEY POINTS • CVD is highly prevalent in patients with CKD. Both conditions seem to worsen each other’s prognosis and complicate most interventions. • The most common cause of death…
KEY POINTS • Heart disease remains the number one cause of death in women worldwide. • Compared with men, women with symptoms consistent with IHD often present without obstructive CAD…
